(Pexels) However, according to a recent study, it was observed that women accumulate more of the tau protein associated with ...

Dementia biomarkers -- phosphorylated tau (P-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) - ...

ARUP Laboratories now provides a blood test for phosphorylated tau 217 (pTau 217) to assist in identifying whether cognitive decline symptoms in patients ages 60 years and older are related to ...

Explore how risk factors for Alzheimer's can impact cognitive function as early as age 24, paving the way for prevention strategies.

A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...

A new study reveals that cognitive changes tied to Alzheimer's risk factors begin far earlier in life than previously thought, some as early as age 24.

Single and multi-dose studies of the small molecule TREM2 agonist VG-3927 clear early safety hurdle. Meanwhile, new findings ...

A study involving over 1,700 participants from five hospitals across Barcelona, Sweden, and Italy has confirmed the ...

A new study confirms that plasma p-tau181 levels can identify subjective cognitive decline (SCD) as a distinct early stage of ...

Industry Veterans Bring Deep Strategic Experience to Guide Alzheimer’s Clinical Expansion and Commercial Strategy POTOMAC, MARYLAND / ACCESS Newswire / April 21, 2025 / IGC Pharma, Inc. (NYSE American ...

This process can lead to the accumulation of amyloid β-peptides and tau proteins in the brain. These proteins would usually be cleared during sleep by the activity of the glymphatic pathway and so ...